HomeTopics › Dental Amalgam

Dental Amalgam

GMJ News knowledge hub · last reviewed September 2026 · Georgian Medical Journal

SummaryStatisticsGlossaryGMJ newsFAQDocumentsOrganizationsResearch

Half of an amalgam filling is mercury, and that single fact has powered fifty years of fear — but the evidence file reads differently: major reviews across regulators find no demonstrated harm from amalgam fillings in the general population at the exposures involved, the diseases attributed to them (Alzheimer’s, MS, chronic fatigue) show no causal link, and the clearest documented harm in this story belongs to unnecessary removal — which spikes mercury exposure and destroys sound teeth — sold by a “holistic dentistry” industry this collection recognises on sight; meanwhile amalgam is genuinely being phased out worldwide, including an EU ban from 2025, for environmental mercury reasons and precaution in specific groups, not because your fillings are poisoning you. The separation of ledgers is below (see the WHO oral health fact sheet).

Key messages

THE MATERIAL AND THE FEAR: half mercury, fully scrutinised
Dental amalgam — the silver-grey filling material used for 150+ years — is roughly 50% elemental mercury alloyed with silver, tin and copper, and it does release mercury vapour in tiny amounts, measurably increased by chewing, grinding and hot liquids: both facts are conceded by every regulator and are the fear's entire foundation. The questions that matter are dose and outcome: absorbed mercury from a mouthful of amalgams contributes an exposure comparable to or below dietary and environmental background for most people, urinary mercury in amalgam-bearers sits far below occupational effect thresholds, and — decisively — half a century of studies hunting for health consequences at these doses has not found them. Elemental mercury vapour is a real neurotoxin at real doses (this is not a "mercury is harmless" hub); amalgam's doses are the point, and the collection's oldest rule — the dose makes the poison — is this controversy's entire skeleton.
THE EVIDENCE FILE: trials, reviews and the diseases that never linked
The claim set is unusually well tested. Randomised evidence exists — rare for a dental material: the two children's amalgam trials (New England and Portugal, ~1,000 children randomised to amalgam or composite) found no differences in neuropsychological, renal or neurological outcomes over 5-7 years — the strongest possible design answering the strongest version of the fear. Systematic reviews by the EU's scientific committees, the FDA, and health agencies worldwide converge: no consistent evidence links amalgam to Alzheimer's, multiple sclerosis, Parkinson's, kidney disease, autism, chronic fatigue or the symptom clusters attributed to "mercury toxicity" in the removal industry's marketing. True positives stay honest: genuine mercury allergy exists (rare, presenting as local lichenoid reactions — a real indication for targeted replacement), and occupational historical exposure in dental staff before modern hygiene was a legitimate issue since engineered away. The gap between "detectable vapour" and "demonstrated harm" is where this entire controversy lives, and fifty years of looking has not closed it.
THE REMOVAL INDUSTRY: where the documented harm actually sits
The clearest iatrogenic harm in the amalgam story belongs to the cure: drilling out intact amalgams produces the highest mercury exposure spike in the material's life cycle — acute vapour and particulate far above anything the resting filling releases — while destroying sound tooth structure (every replacement enlarges the cavity and shortens the tooth's lifespan) for zero demonstrated health benefit in non-allergic patients. Around this procedure grew "holistic" and "biological" dentistry: mercury-free branding, unvalidated diagnostic theatre (hair analysis, "provoked" urine tests that manufacture alarming numbers by design), chelation courses with real risks sold as detox, and symptom checklists broad enough to recruit anyone — the full marketplace anatomy this collection documents from supplements to IV drips, here with a drill. Regulators' verdicts are explicit: routine removal of functional amalgams is not recommended anywhere, and the SMART protocols marketed as protection during unnecessary removal do not convert an unindicated procedure into an indicated one.
THE PHASE-OUT PARADOX: banned for the planet, not the patient
Amalgam is genuinely disappearing, and reading the reasons correctly is this hub's subtlest task. The Minamata Convention — the global mercury treaty — mandates phase-down of dental amalgam as part of eliminating anthropogenic mercury releases (dentistry is a meaningful contributor to environmental mercury, via clinic wastewater and cremation emissions); the EU banned amalgam use from January 2025 (narrow medical exemptions) explicitly on environmental grounds; and precautionary carve-outs preceded it — several countries and the FDA's 2020 advisory recommend avoiding new amalgams in pregnant and breastfeeding women, young children and people with kidney impairment: precaution for theoretically susceptible groups, stated as such, not findings of harm. The paradox to hold: a material can be worth retiring for environmental-mercury and better-alternatives reasons while the your-fillings-are-poisoning-you claim remains unsupported — and the phase-out is systematically misquoted as vindication by the removal industry. Composite alternatives, meanwhile, carry their own honest file: shorter average lifespan in large restorations, technique sensitivity, and their own micro-controversy (bisphenol-derived monomers) that the same fear economy recycles.
WHAT THIS CASE TEACHES THE COLLECTION
Amalgam is a compact masterclass in the collection's mechanisms. Detectability confusion: modern instruments measure vapour molecules; measurement is not toxicity, and "mercury detected" does the fear's work while the dose does the science's. Chemophobia with a true premise: unlike MSG or GMO fears built on false mechanisms, this one starts from a real neurotoxin — making dose-literacy, not mechanism-debunking, the necessary tool. Vindication laundering: an environmental phase-out is retailed as a safety confession — watch the reasons, not the headline. Symptom-checklist recruitment: fatigue, brain fog and anxiety are near-universal; any industry offering a removable cause for them will never lack patients. And the both-directions institutional lesson: dentistry's early dismissiveness and the slow arrival of susceptible-group precaution fed distrust that the removal industry then monetised — candour about uncertainty, stated early, is cheaper than the credibility interest paid later.
PRACTICAL BOTTOM LINE
If you have amalgam fillings and no symptoms: leave them alone — the resting filling is the low-exposure state, removal is the high-exposure event, and no health benefit from prophylactic removal has ever been demonstrated; replace amalgams when they fail clinically, with composite or other alternatives as modern practice now defaults anyway. If you have symptoms you suspect are mercury: seek real evaluation (the differential for fatigue-fog clusters is long) and refuse the theatre — hair tests and provoked urines are designed to alarm, and chelation without genuine poisoning is a harm, not a detox. If you are pregnant, breastfeeding, or choosing for a young child: new fillings will almost certainly be mercury-free by default and precaution supports that — while existing amalgams should still not be removed during pregnancy (the removal spike is the exposure). If a genuine oral lichenoid reaction adjacent to an amalgam is diagnosed: targeted replacement of that filling is the legitimate indication. And in every consulting room: a dentist leading with detox language, provoked tests and whole-mouth removal quotes has told you the diagnosis — of the practice.

Key statistics

~50%
elemental mercury content of dental amalgam — the true premise on which fifty years of unconfirmed harm claims were built
Material composition standards
~1,000
children in the two randomised amalgam trials — no neuropsychological, renal or neurological differences versus composite over 5-7 years
Children's Amalgam Trials (NEJM/JAMA 2006)
No consistent link
between amalgam and Alzheimer's, MS, Parkinson's, kidney disease, autism or chronic fatigue across systematic reviews by EU, FDA and international bodies
SCENIHR / FDA / WHO reviews
2020
the FDA advisory recommending non-amalgam alternatives for pregnant/breastfeeding women, young children and renal-impaired patients — stated precaution, not a harm finding
FDA amalgam communication
Jan 2025
the EU's ban on new dental amalgam use — enacted on environmental mercury grounds under the Minamata framework, with narrow medical exemptions
EU mercury regulation 2024
Removal
the highest mercury-exposure event in an amalgam's life cycle — the documented reason routine removal of intact fillings is recommended nowhere
Exposure-during-removal studies

Where the disagreement actually lies

Each claim scored by strength of evidence — not by popularity.

Amalgam releases measurable mercury vapour (true, tiny doses)Strong · 90
Health harm at amalgam doses in the general population (not demonstrated)Weak · 15
Amalgam causes Alzheimer's/MS/autism (unsupported across reviews)Weak · 8
Susceptible-group precaution for new fillings (reasonable, adopted)Contested · 70
Routine removal of intact amalgams (harmful theatre)Weak · 8
Environmental phase-out rationale (real — and distinct from patient safety)Strong · 85
Strong settledContested genuinely openWeak unsupported

Source: Editorial synthesis of randomised trials, regulatory reviews and exposure studies

Glossary of key terms

Elemental mercury vapour
exposure
The form amalgam releases — inhaled and absorbed, neurotoxic at occupational doses; amalgam-bearers' absorbed dose sits at or below dietary-environmental background, the ratio the whole debate turns on.
Children's Amalgam Trials
evidence
The two randomised trials (~1,000 children, amalgam vs composite, 5-7 years) finding no neurodevelopmental or renal differences — the rare RCT answer to a toxicity scare, and this hub's evidentiary anchor.
Oral lichenoid reaction
clinical
The genuine amalgam-related condition: a localised mucosal reaction adjacent to a filling in contact-allergic patients — rare, diagnosable, and the one honest indication for targeted replacement.
Provoked urine testing
theatre
Chelator-administered-then-measured urine mercury — a protocol that inflates values by design against reference ranges built for unprovoked samples; the removal industry's core diagnostic instrument.
Minamata Convention
policy
The global mercury treaty driving amalgam phase-down for environmental reasons — the document the removal industry misquotes as a safety confession.
SMART removal
marketing
The “safe mercury amalgam removal technique” protocols — reasonable engineering controls for clinically indicated removals, marketed as licence for unindicated ones; precaution repurposed as sales.

Latest GMJ coverage

Articles will appear here as the archive grows.

Frequently asked questions 12 Q&A — structured for Google featured snippets and AI discovery

Knowledge hub: guidelines, conventions and reports

Organizations working in migration and health

Related health topics

Oral HealthDetox and Alkaline ClaimsEndocrine DisruptorsHealth MisinformationLow-Value CareMedicalisation

About this hub. Produced by the GMJ News Editorial Team as a public-good service. Every statistic is linked to its primary source. Documents are preserved in the GMJ Repository with full attribution. Georgian Medical Journal · Contact the editorial team
© 2026 GMJ News · PHIG · Sheni Network